非HIV卡波西肉瘤中的自身免疫性大疱性疾病:一项大型患者队列的回顾性研究
研究回顾性分析了1990至2016年间该科室随访的1362例经典或医源性非HIV卡波西肉瘤患者,其中14例(1.03%)合并大疱性疾病,包括9例大疱性类天疱疮、3例局限性大疱性类天疱疮和2例寻常型天疱疮。作者认为大疱性疾病在卡波西肉瘤患者中似乎更常见,支持HHV-8可能参与其发病机制的假说,治疗时需考虑糖皮质激素诱发卡波西肉瘤的潜在风险。
要点
- 1362例非HIV卡波西肉瘤患者中14例(1.03%)合并大疱性疾病。
- 14例中9例为大疱性类天疱疮,3例为局限性大疱性类天疱疮,2例为寻常型天疱疮。
- 使用糖皮质激素时卡波西肉瘤如预期般加重。
核心结论
- 大疱性疾病在卡波西肉瘤患者中似乎更常见,支持HHV-8可能参与其发病机制的假说。
- 此类病例的治疗管理应考虑糖皮质激素诱发卡波西肉瘤的潜在风险。
研究设计与样本
- 回顾性综述,纳入1990年至2016年间在该科室随访的所有非HIV卡波西肉瘤合并大疱性疾病患者。
- 共1362例经典或医源性卡波西肉瘤患者,其中14例(1.03%)合并大疱性疾病。
主要发现
- 14例中9例(0.66%)为大疱性类天疱疮,3例(0.22%)为局限性大疱性类天疱疮,2例(0.15%)为寻常型天疱疮。
- 两种疾病诊断时的平均年龄为85.8岁,男女比例为9:5。
- 7例先诊断卡波西肉瘤后发生大疱性疾病,其余7例先发生大疱性疾病后诊断卡波西肉瘤。
- 使用糖皮质激素时卡波西肉瘤如预期般加重。
临床怎么用
- 作者认为此类病例的治疗管理应考虑糖皮质激素诱发卡波西肉瘤的潜在风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kaposi's sarcoma (KS) is a rare endothelial neoplasm caused by the human herpesvirus 8 (HHV-8). Its risk is increased in immunocompromised patients, including those undergoing immunosuppressive therapy for autoimmune bullous diseases. Conversely, HHV-8 infection has been hypothesized to be a triggering factor of bullous diseases, especially pemphigus. Given the fact that both KS and autoimmune bullous diseases have a low incidence in the general population, it could be expected that the association between these disorders would be exceptional. OBJECTIVES: To assess the frequency of bullous diseases in a large cohort of non-HIV KS patients and to describe our experience concerning the clinical features, natural history and treatment options in this setting. METHODS: We performed a retrospective review of all patients with non-HIV KS in association with bullous disease followed at our department between 1990 and 2016. Medical records were reviewed for demographics, medical history, clinical characteristics and treatment. RESULTS: Among 1362 patients with classic or iatrogenic KS, 14 (1.03%) also suffered from bullous disease. The mean age at diagnosis of both disorders was 85.8 years with a male/female ratio of 9 : 5. Among these 14 cases, nine (0.66%) were associated with bullous pemphigoid (BP), three (0.22%) with localized BP and two (0.15%) with pemphigus vulgaris. Seven had developed a bullous disease after being diagnosed with KS, while in the remaining seven cases, KS developed after the onset of bullous disease. As expected, KS worsened when corticosteroids were used. CONCLUSION: Bullous diseases seem to be more frequent among patients with KS, supporting the hypothesis that HHV-8 may be involved in their pathogenesis. Therapeutic management of these cases should take into account KS-inducing potential of corticosteroids.
引用
- Tourlaki A, Genovese G, Guanziroli E, et al. Autoimmune bullous diseases in non-HIV Kaposi's sarcoma: a retrospective study in a large cohort of patients. J Eur Acad Dermatol Venereol. 2018. PMID: 29729120. doi:10.1111/jdv.15051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。